- Home
- BIIB vs AWK Comparison
BIIB vs AWK Comparison
Compare BIIB & AWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIIB
- AWK
- Stock Information
- Founded
- BIIB 1978
- AWK 1886
- Country
- BIIB United States
- AWK United States
- Employees
- BIIB N/A
- AWK N/A
- Industry
- BIIB Biotechnology: Pharmaceutical Preparations
- AWK Water Supply
- Sector
- BIIB Health Care
- AWK Utilities
- Exchange
- BIIB Nasdaq
- AWK Nasdaq
- Market Cap
- BIIB 24.2B
- AWK 26.4B
- IPO Year
- BIIB 1991
- AWK 2008
- Fundamental
- Price
- BIIB $175.74
- AWK $132.89
- Analyst Decision
- BIIB Buy
- AWK Hold
- Analyst Count
- BIIB 23
- AWK 10
- Target Price
- BIIB $176.48
- AWK $143.30
- AVG Volume (30 Days)
- BIIB 2.0M
- AWK 2.2M
- Earning Date
- BIIB 10-30-2025
- AWK 10-29-2025
- Dividend Yield
- BIIB N/A
- AWK 2.58%
- EPS Growth
- BIIB N/A
- AWK 13.02
- EPS
- BIIB 10.97
- AWK 5.69
- Revenue
- BIIB $10,065,900,000.00
- AWK $5,070,000,000.00
- Revenue This Year
- BIIB $2.97
- AWK $8.18
- Revenue Next Year
- BIIB N/A
- AWK $5.86
- P/E Ratio
- BIIB $15.97
- AWK $23.33
- Revenue Growth
- BIIB 4.77
- AWK 12.29
- 52 Week Low
- BIIB $110.04
- AWK $118.74
- 52 Week High
- BIIB $176.02
- AWK $155.50
- Technical
- Relative Strength Index (RSI)
- BIIB 76.31
- AWK 50.20
- Support Level
- BIIB $165.75
- AWK $125.91
- Resistance Level
- BIIB $170.78
- AWK $133.31
- Average True Range (ATR)
- BIIB 5.16
- AWK 2.96
- MACD
- BIIB 1.34
- AWK 0.34
- Stochastic Oscillator
- BIIB 98.74
- AWK 85.75
About BIIB Biogen Inc.
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
About AWK American Water Works Company Inc.
American Water Works is the largest investor-owned US water and wastewater utility, serving nearly 4 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns.